Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient

In recent years, the evolution of treatments has made it possible to significantly improve the outcomes of patients with non-small cell lung cancer (NSCLC). In particular, while molecular targeted therapies are effective in specific patient sub-groups, immune checkpoint inhibitors (ICIs) have greatl...

Full description

Saved in:
Bibliographic Details
Published in:Cancers (Basel)
Main Authors: Rossi, Giovanni, Russo, Alessandro, Tagliamento, Marco, Tuzi, Alessandro, Nigro, Olga, Vallome, Giacomo, Sini, Claudio, Grassi, Massimiliano, Dal Bello, Maria Giovanna, Coco, Simona, Longo, Luca, Zullo, Lodovica, Tanda, Enrica Teresa, Dellepiane, Chiara, Pronzato, Paolo, Genova, Carlo
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7281184/
https://ncbi.nlm.nih.gov/pubmed/32365882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12051125
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items